VTE Risks and JAK inhibition
Mar 13, 2023
Daily Download
SLE - New Drug Development
Jan 06, 2023
JAKi Regulatory Decisions - FDA, EMA, Canada
Nov 15, 2022
Oral Surveillance study resulted in a new FDA drug safety bulleting 9/21/21 and since the label for all JAK inhibitors has changed (FDA, Canada) or will change (EMA).
Smart Rules for Patients
May 10, 2022
PsA: Therapeutic Interventions
Apr 25, 2022
FDA EUA for Baricitinib in COVID
Oct 20, 2021